Anti-lipolysis-stimulated lipoprotein receptor monoclonal antibody as a novel therapeutic agent for endometrial cancer.
Nagase Y, Hiramatsu K, Funauchi M, Shiomi M, Masuda T, Kakuda M, Nakagawa S, Miyoshi A, Matsuzaki S, Kobayashi E, Kimura T, Serada S, Ueda Y, Naka T, Kimura T.
Nagase Y, et al. Among authors: funauchi m.
BMC Cancer. 2022 Jun 21;22(1):679. doi: 10.1186/s12885-022-09789-6.
BMC Cancer. 2022.
PMID: 35729527
Free PMC article.